BRAND_ANALYSIS #BIONTECH HEALTH & PHARMA #25 OF 26 IN HEALTH & PHARMA ALIGNED

BioNTech

· Public · Updated 09 Sep 2026 07:29 UTC
#1122 of 1208 overall by tension · #25 of 26 in Health & Pharma
4 Aligned
The Rising Underdog
Analysis

BioNTech's cultural score (50) has cratered from pandemic prominence, now running negative sentiment (-0.50) despite 5.33% stock gains. The absence of wiki data is itself revealing: a company that saved millions is already fading from collective memory.

IN THE NEWS (52 articles this week)
BioNTech Shares Fall After BMO Downgrade and Price Target Cut - Yahoo Finance
FDA Approves Pfizer-BioNTech XFG-Adapted COVID-19 Vaccine for 2026-27 Season - Patient Care Online
Alumis & BioNTech Stumble, Lilly Buys Merida, & Takeda’s Latest FDA Approval - Timmerman Report
Cultural Score
50 / 100
Business Score
46 / 100
TENSION▁▁▁▂▁▁▂▃▂▁▁▁▁▁
CULTURAL▄▄▃▆▄▄▆▄▅▄▄▄▄▄
BUSINESS▃▃▃▄▄▄▄▂▄▄▄▄▄▄
Loading...
Wikipedia Momentum 15/40
News Presence 36/35
Search InterestRedistributed to other dimensions
Stock Momentum 24/30
Market Position 16/25
Revenue Growth 3/25
Earnings Health 3/20
Price$98.66
30d Change+5.3%
Market Cap$24.8B
Profit Margin-63.6%
BioNTech's tension is 4. Culture outpacing commerce. sociologyofcapitalism.com/brand/biontech
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/biontech.html" width="320" height="200" frameborder="0"></iframe>